CY1107565T1 - Ιμιδαζο-πυριμιδινες και τριαζολο-πιριμιδινες: συνδεσμοι υποδοχεα βανζοδιαζεπινης - Google Patents
Ιμιδαζο-πυριμιδινες και τριαζολο-πιριμιδινες: συνδεσμοι υποδοχεα βανζοδιαζεπινηςInfo
- Publication number
- CY1107565T1 CY1107565T1 CY20071100262T CY071100262T CY1107565T1 CY 1107565 T1 CY1107565 T1 CY 1107565T1 CY 20071100262 T CY20071100262 T CY 20071100262T CY 071100262 T CY071100262 T CY 071100262T CY 1107565 T1 CY1107565 T1 CY 1107565T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pyrimides
- methods
- compounds
- cns
- vanzodiazepin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 102000027484 GABAA receptors Human genes 0.000 abstract 2
- 108091008681 GABAA receptors Proteins 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 230000004807 localization Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49000603P | 2003-07-25 | 2003-07-25 | |
| US54308304P | 2004-02-09 | 2004-02-09 | |
| EP04779031A EP1648899B1 (en) | 2003-07-25 | 2004-07-23 | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107565T1 true CY1107565T1 (el) | 2013-03-13 |
Family
ID=34118813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100262T CY1107565T1 (el) | 2003-07-25 | 2007-02-26 | Ιμιδαζο-πυριμιδινες και τριαζολο-πιριμιδινες: συνδεσμοι υποδοχεα βανζοδιαζεπινης |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7271170B2 (https=) |
| EP (1) | EP1648899B1 (https=) |
| JP (1) | JP2007500130A (https=) |
| KR (1) | KR20060098425A (https=) |
| AR (1) | AR045117A1 (https=) |
| AT (1) | ATE350382T1 (https=) |
| AU (1) | AU2004261591A1 (https=) |
| BR (1) | BRPI0412908A (https=) |
| CA (1) | CA2537331A1 (https=) |
| CY (1) | CY1107565T1 (https=) |
| DE (1) | DE602004004143T2 (https=) |
| DK (1) | DK1648899T3 (https=) |
| ES (1) | ES2278345T3 (https=) |
| IL (1) | IL173265A0 (https=) |
| MX (1) | MXPA06000887A (https=) |
| NZ (1) | NZ544262A (https=) |
| PL (1) | PL1648899T3 (https=) |
| PT (1) | PT1648899E (https=) |
| TW (1) | TW200524937A (https=) |
| WO (1) | WO2005012306A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| CA2524376A1 (en) * | 2003-05-05 | 2004-12-16 | Neurogen Corporation | Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands |
| US20080167324A1 (en) * | 2005-03-02 | 2008-07-10 | Yuelian Xu | Thiazolymethyl and Oxazolylmethyl Heteroaryl Derivatives |
| US7709468B2 (en) | 2005-09-02 | 2010-05-04 | Abbott Laboratories | Imidazo based heterocycles |
| EP2146576A4 (en) * | 2007-04-11 | 2013-01-16 | Cypress Bioscience Inc | TREATMENT OF DOWN SYNDROME WITH BENZODIAZEPINE REACTANT AGONISTS |
| US8546394B2 (en) | 2007-04-17 | 2013-10-01 | Bristol-Myers Squibb Company | Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors |
| GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| US20090270373A1 (en) * | 2008-04-11 | 2009-10-29 | Cypress Biosciences, Inc. | Treatment of down syndrom with benzodiazepine receptor antagonists |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US544057A (en) * | 1895-08-06 | Bill and letter file | ||
| AU4058000A (en) * | 1999-04-02 | 2000-10-23 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors |
| US6737242B1 (en) * | 1999-05-07 | 2004-05-18 | Neurogen Corporation | Methods for screening GABA-modulatory compounds for specified pharmacological activities |
| GB9929687D0 (en) * | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
| AU2001270297A1 (en) * | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
| GB0027561D0 (en) | 2000-11-10 | 2000-12-27 | Merck Sharp & Dohme | Therapeutic agents |
| US6900215B2 (en) * | 2000-12-15 | 2005-05-31 | Merck Sharp & Dohme Ltd. | Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
| TWI248936B (en) * | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| ATE338758T1 (de) | 2001-03-23 | 2006-09-15 | Merck Sharp & Dohme | Imidazopyrimidin-derivate als liganden für gaba- rezeptoren |
| IL159811A0 (en) * | 2001-07-13 | 2004-06-20 | Neurogen Corp | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| JP2005531548A (ja) * | 2002-05-02 | 2005-10-20 | ニューロジェン コーポレイション | 置換イミダゾール誘導体：ｇａｂａａ受容体リガンド |
| JP2006515278A (ja) * | 2002-05-08 | 2006-05-25 | ニューロジェン コーポレイション | 置換イミダゾリルメチルピリジン及びピラジン誘導体並びにそれらのｇａｂａａ受容体リガンドとしての使用 |
| DE60306918T2 (de) * | 2002-05-17 | 2007-03-01 | Neurogen Corp., Branford | Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden |
| CN100579579C (zh) * | 2002-10-01 | 2010-01-13 | 诺华疫苗和诊断公司 | 抗癌及抗感染性疾病组合物及其使用方法 |
| ATE335732T1 (de) | 2002-11-08 | 2006-09-15 | Neurogen Corp | 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren |
| CA2524376A1 (en) | 2003-05-05 | 2004-12-16 | Neurogen Corporation | Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands |
-
2004
- 2004-07-23 WO PCT/US2004/023794 patent/WO2005012306A2/en not_active Ceased
- 2004-07-23 JP JP2006521278A patent/JP2007500130A/ja active Pending
- 2004-07-23 PT PT04779031T patent/PT1648899E/pt unknown
- 2004-07-23 MX MXPA06000887A patent/MXPA06000887A/es active IP Right Grant
- 2004-07-23 EP EP04779031A patent/EP1648899B1/en not_active Expired - Lifetime
- 2004-07-23 KR KR1020067001782A patent/KR20060098425A/ko not_active Ceased
- 2004-07-23 PL PL04779031T patent/PL1648899T3/pl unknown
- 2004-07-23 DE DE602004004143T patent/DE602004004143T2/de not_active Expired - Lifetime
- 2004-07-23 AU AU2004261591A patent/AU2004261591A1/en not_active Abandoned
- 2004-07-23 ES ES04779031T patent/ES2278345T3/es not_active Expired - Lifetime
- 2004-07-23 US US10/898,690 patent/US7271170B2/en not_active Expired - Lifetime
- 2004-07-23 AT AT04779031T patent/ATE350382T1/de not_active IP Right Cessation
- 2004-07-23 BR BRPI0412908-3A patent/BRPI0412908A/pt not_active IP Right Cessation
- 2004-07-23 DK DK04779031T patent/DK1648899T3/da active
- 2004-07-23 CA CA002537331A patent/CA2537331A1/en not_active Abandoned
- 2004-07-23 NZ NZ544262A patent/NZ544262A/xx unknown
- 2004-07-26 AR ARP040102649A patent/AR045117A1/es unknown
- 2004-07-26 TW TW093122247A patent/TW200524937A/zh unknown
-
2006
- 2006-01-19 IL IL173265A patent/IL173265A0/en unknown
-
2007
- 2007-02-26 CY CY20071100262T patent/CY1107565T1/el unknown
- 2007-09-14 US US11/855,386 patent/US20080139580A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ544262A (en) | 2009-06-26 |
| WO2005012306A2 (en) | 2005-02-10 |
| DK1648899T3 (da) | 2007-04-02 |
| ATE350382T1 (de) | 2007-01-15 |
| MXPA06000887A (es) | 2006-04-19 |
| KR20060098425A (ko) | 2006-09-18 |
| US7271170B2 (en) | 2007-09-18 |
| DE602004004143D1 (de) | 2007-02-15 |
| JP2007500130A (ja) | 2007-01-11 |
| ES2278345T3 (es) | 2007-08-01 |
| PT1648899E (pt) | 2007-03-30 |
| PL1648899T3 (pl) | 2007-06-29 |
| EP1648899A2 (en) | 2006-04-26 |
| BRPI0412908A (pt) | 2006-09-26 |
| US20050038043A1 (en) | 2005-02-17 |
| WO2005012306A3 (en) | 2005-04-14 |
| TW200524937A (en) | 2005-08-01 |
| EP1648899B1 (en) | 2007-01-03 |
| US20080139580A1 (en) | 2008-06-12 |
| IL173265A0 (en) | 2006-06-11 |
| AU2004261591A1 (en) | 2005-02-10 |
| HK1089446A1 (en) | 2006-12-01 |
| DE602004004143T2 (de) | 2007-10-11 |
| AR045117A1 (es) | 2005-10-19 |
| CA2537331A1 (en) | 2005-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107565T1 (el) | Ιμιδαζο-πυριμιδινες και τριαζολο-πιριμιδινες: συνδεσμοι υποδοχεα βανζοδιαζεπινης | |
| WO2007133561A3 (en) | Substituted azaspiro derivatives | |
| NO20083153L (no) | Kjemiske forbindelser | |
| EA200301213A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
| TW200716594A (en) | Substituted heteroaryl CB1 antagonists | |
| DE602007011904D1 (de) | Piperazinyl-oxoalkyl-tetrahydroisochinoline und verwandte analoga | |
| EP1473987A4 (en) | DEVICE FOR TRANSPORTING LABORATORY | |
| WO2006052546A3 (en) | Pyrazolylmethyl heteroaryl derivatives | |
| MX2009013897A (es) | Piperacinil oxoalquil tetrahidro-beta-carbolinas y analogos relacionados. | |
| BRPI0407305A (pt) | Ligantes do receptor de canabinóides e seus usos | |
| CY1107851T1 (el) | Παραγωγα πυρολλο-πυριδινης και η χρηση τους ως ανταγωνιστων crth2 | |
| DE60315677D1 (de) | Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs | |
| SE0301700D0 (sv) | Novel compounds | |
| EA200500520A1 (ru) | Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов | |
| CY1110137T1 (el) | Συμπυκνωμενες τρικυκλικες ενωσεις peri χρησιμες ως αντιβακτηριακοι παραγοντες | |
| JO2578B1 (en) | Compounds Theophene benzimidazole | |
| BRPI0518794A2 (pt) | composto, composiÇço, mÉtodo de tratamento de distérbio hiperproliferativo, e, biblioteca combinatorial | |
| PT1244650E (pt) | Derivados arilaminas e sua aplicacao como agentes anti-telomerase | |
| UY30736A1 (es) | Compuestos quimicos 537 | |
| ES2167436T3 (es) | Tabletas de flubendazol masticables para animales de compañia. | |
| CR8387A (es) | Compuestos de pirazolilo e imidazolilo biciclicos y uso de los mismos | |
| ECSP055964A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
| CY1111256T1 (el) | Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους | |
| ATE523495T1 (de) | Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente | |
| CY1113059T1 (el) | Οργανικες ενωσεις |